Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A, Volume 365 in the International Review of Cell and Molecular Biology series reviews and details current advances in cell and molecular biology. Chapters in this new release include MPN a continuum of different disease entities, Bone marrow microenvironment of MPN, Extramedullary hemopoiesis in MPN, The JAK2 mutation, Calreticulin mutations in myeloproliferative neoplasms, and Cytogenetic abnormalities and non-driver mutations in MPN. The IRCMB series has a worldwide readership, maintaining a high standard by publishing invited articles on important and timely topics that are authored by prominent cell and molecular biologists.
The articles published in IRCMB have a high impact and an average cited half-life of 9 years. This great resource ranks high amongst scientific journals dealing with cell biology.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectives - p. ix 8. Chapter One: Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities - p. 16 9. Chapter Two: Bone marrow microenvironment of MPN cells - p. 71 10. Chapter Three: Extramedullary hematopoiesis in myeloproliferative neoplasms: Pathophysiology and treatment strategies - p. 97 11. Chapter Four: The JAK2 mutation - p. 117 12. Chapter Five: The MPL mutation - p. 167 13. Chapter Six: Calreticulin mutations in myeloproliferative neoplasms - p. 179
Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A, Volume 365 in the International Review of Cell and Molecular Biology series reviews and details current advances in cell and molecular biology. Chapters in this new release include MPN a continuum of different disease entities, Bone marrow microenvironment of MPN, Extramedullary hemopoiesis in MPN, The JAK2 mutation, Calreticulin mutations in myeloproliferative neoplasms, and Cytogenetic abnormalities and non-driver mutations in MPN. The IRCMB series has a worldwide readership, maintaining a high standard by publishing invited articles on important and timely topics that are authored by prominent cell and molecular biologists.
The articles published in IRCMB have a high impact and an average cited half-life of 9 years. This great resource ranks high amongst scientific journals dealing with cell biology.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectives - p. ix 8. Chapter One: Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities - p. 16 9. Chapter Two: Bone marrow microenvironment of MPN cells - p. 71 10. Chapter Three: Extramedullary hematopoiesis in myeloproliferative neoplasms: Pathophysiology and treatment strategies - p. 97 11. Chapter Four: The JAK2 mutation - p. 117 12. Chapter Five: The MPL mutation - p. 167 13. Chapter Six: Calreticulin mutations in myeloproliferative neoplasms - p. 179
